课题基金 / 基金详情

Combination Antithrombotic Thrombotic therapy for prevention of recurrent Ischemic Stroke in patients with IntraCranial Atherosclerotic Disease (CATIS-ICAD)

Combination Antithrombotic Thrombotic therapy for prevention of recurrent Ischemic Stroke in patients with IntraCranial Atherosclerotic Disease (CATIS-ICAD)
联合抗血栓治疗预防颅内动脉粥样硬化性疾病患者复发性缺血性中风 (CATIS-ICAD)
批准号：
444831
负责人：
Perera Kanjana S
金额：
$24.52万
依托单位：
McMaster University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-04-01 至 2023-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=444831&lang=en
关键词：
Combination Antithrombotic Therapy Intracranial Atherosclerotic Disease Ischemic Stroke Low-Dose Rivaroxaban Plus Aspirin Rivaroxaban Stroke Secondary Prevention Transient Ischemic Attack

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Stroke is the 3rd leading cause of death and primary cause of disability in Canada and globally. Stroke caused by narrowing of the brain arteries from cholesterol plaques is the commonest cause of stroke. Many patients with narrowing of brain arteries suf
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金